148 related articles for article (PubMed ID: 7678064)
1. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.
Hillmen P; Bessler M; Crawford DH; Luzzatto L
Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064
[TBL] [Abstract][Full Text] [Related]
2. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
3. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
4. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.
Terstappen LW; Nguyen M; Huang S; Lazarus HM; Medof ME
Br J Haematol; 1993 Jul; 84(3):504-14. PubMed ID: 7692931
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood harvest of unaffected CD34+ CD38- hematopoietic precursors in paroxysmal nocturnal hemoglobinuria.
Prince GM; Nguyen M; Lazarus HM; Brodsky RA; Terstappen LW; Medof ME
Blood; 1995 Nov; 86(9):3381-6. PubMed ID: 7579441
[TBL] [Abstract][Full Text] [Related]
6. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
7. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
8. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
Hillmen P; Hows JM; Luzzatto L
Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
10. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
Nilsson B; Hagström U; Englund A; Säfwenberg J
Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
12. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
[TBL] [Abstract][Full Text] [Related]
14. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria.
Nakakuma H; Nagakura S; Kawaguchi T; Iwamoto N; Hidaka M; Horikawa K; Kagimoto T; Tsuruzaki R; Takatsuki K
Blood; 1994 Dec; 84(11):3925-8. PubMed ID: 7524752
[TBL] [Abstract][Full Text] [Related]
15. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
16. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
Fujioka S; Yamada T
Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
[TBL] [Abstract][Full Text] [Related]
17. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
18. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
[TBL] [Abstract][Full Text] [Related]
19. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
